Stanford School of Medicine
SPECTRUM- the Stanford Center for Clinical and Translational Education and Research
Requests for Pilot Project Proposals:
Pilot Projects that have the Objective of Translating Technology into Novel Medtech, Biopharma, or Diagnostic Projects
 |
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||
Internal funding opportunity for Stanford graduate students, postdoctoral fellows, or faculty in the Schools of Medicine, Engineering, Earth Sciences, Humanities and Science, or Business.
Deadline: September 30, 2009
(see internal proposal submission guidelines)
Amount of funding:
Typical grants will range from $25,000-50,000/year, with the possibility of a single renewal. Grants will be administered by Spectrum under the guidance of Biodesign (medical
devices) or SPARK (drugs and diagnostics).
Eligibility
Summary proposals may be submitted by Stanford graduate students, postdoctoral fellows, or faculty in the Schools of Medicine, Engineering, Earth Sciences, Humanities and Science, or Business.
Program
The Stanford School of Medicine and Spectrum - the Stanford Center for Clinical and Translational Education and Research - are soliciting proposals for grants for pilot projects that have the objective of translating technology into novel medtech, biopharma, or diagnostic
products.
The funding for the pilot projects is made possible via Stanford's NIH CTSA grant.
Special consideration will be given to projects that address unmet medical needs and are less likely to be developed by industry. Some examples would include devices or drugs for orphan indications (prevalence <200,000 in the US), or for diseases or health delivery issues unique to
less developed countries.
Internal Proposal Submission Guidelines
By Sept. 30, 2009, please submit your proposal via email as follows:
• Drug, biologic, or diagnostic proposals to Kevin Grimes at kgrimes@stanford.edu
• Device Proposals to Dawn Wojick dwojick@stanford.edu
3 page proposal
Pages 1-2 must contain the following:
1. Description of Proposed Product
2. Description of Underlying Technology
3. Clinical Indication/Need and Brief Scope of Market
4. Comparison to Current Standard of Care (in effectiveness and cost)
5. Translational Objectives (what will be achieved with funding)
6. Development Plan
7. Applicant's credentials
Page 3: Anticipated budget
Questions? Contact information
Please email Ari Chaney, achaney@stanford.edu, or Kevin Grimes, kgrimes@stanford.edu, with questions or comments.
